Scholar Rock Holding Corporation (NASDAQ: SRRK) is a Healthcare company (Biotechnology) with a market capitalization of $5.4B. The Maz Rating grades it against the other companies in its sector.
Scholar Rock Holding Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $44.54, Scholar Rock Holding Corporation trades at 9702.5x sales and 35.6x book value. Over the last twelve months it generated about $560066 of revenue and a net loss of $386M. It runs a gross margin of -8236.0%, an operating margin of -71732.3% and a net margin of -72563.2%. It shows return on equity of -175.3%, return on invested capital of -110.0% and a free cash flow yield of -5.7%. On the balance sheet: a debt-to-equity ratio of 1.20 and a current ratio of 5.41. Over the past 52 weeks the share price ranged from $35.53 to $61.76, with a beta of 0.62.
Scholar Rock Holding Corporation does not currently pay a dividend.
15 Wall Street analyst ratings cover the stock: 1 Strong Buy, 12 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.